Investigators from BC Cancer – Prince George (Centre for the North) are co-authors on three international collaborative publications featured in the same issue of The Lancet Oncology. These papers reflect the centre’s engagement in global research collaborations that shape how cancer care is studied, reported, and delivered.
Researchers at BC Cancer Research Institute, led by Dr. Bernie Eigl, director of the Provincial Clinical Trials Office, and Dr. Alex Wyatt, senior scientist and scientific director of the Cancer Genetics and Genomics Laboratory, examined whether a blood test that analyzes cancer-derived DNA found in the blood, called circulating tumour DNA (ctDNA), could help identify more patients with metastatic urothelial carcinoma – an aggressive form of bladder cancer – who are eligible for FGFR-targeted therapy.
Three projects led by BC Cancer researchers and focused on advancing cancer care have been funded through the inaugural UBC AI and Health Network Fellows Program, which supports researchers harnessing artificial intelligence (AI) to transform health research and improve patient care across BC.
Dr. Kim Chi, medical oncologist and clinician-scientist with BC Cancer, has been named a highly cited researcher in 2025 by Clarivate, a global organization that analyzes academic publications, citations and research impact.
“This recognition reflects my career-long commitment to improving care for people with prostate cancer,” says Dr. Kim Chi, medical oncologist, BC Cancer. “Our research has always been driven by the needs of patients, and this honour highlights the collective efforts of our collaborators, co-investigators and dedicated staff who make this work possible.”
Congratulations to the recipients of the BC Cancer Foundation (BCCF) Rising Stars Graduate Awards competition!
This year’s awardees are:
BC Cancer’s 2025 Cancer Emerging Multidisciplinary Research Programs supports research teams to initiate novel multidisciplinary research projects that aim to tackle well-defined issues or problems that affect patients living with cancer or at risk of developing cancer. Funding for the programs is provided through the BC Ministry of Health in collaboration with the BC Cancer Foundation.
2025 Emerging Multidisciplinary Research Programs Recipients:
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.